Yeleswaram Krishnaswamy

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Yeleswaram Krishnaswamy's trades of Rapport Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-21 2026-04-17
PlS Planned sale
83,559 -40.6%
296.53
US$423,299 		83,559 -40.6% 296.53 US$423,299
2026-04-17 2026-04-17
PrS Proposed sale
45,428
301.97
US$3,194,916 		45,428 301.97 US$3,194,916
2026-04-14 2026-04-14
PlS Planned sale
88,307 -7.3%
121.79
US$3,756,929 		88,307 -7.3% 121.79 US$3,756,929
2026-04-14 2026-04-13
PlS Planned sale
9,165 -3.2%
34.97
US$320,537 		9,165 -3.2% 34.97 US$320,537
2026-04-13 2026-04-13
PrS Proposed sale
19,365
34.17
US$661,702 		19,365 34.17 US$661,702
2026-04-14 2026-04-10
PlS Planned sale
500 -0.2%
34.98
US$17,490 		500 -0.2% 34.98 US$17,490
2026-04-10 2026-04-10
PrS Proposed sale
500
34.22
US$17,110 		500 34.22 US$17,110
2026-04-09 2026-04-08
PlS Planned sale
360 -0.1%
34.90
US$12,564 		360 -0.1% 34.90 US$12,564
2026-04-08 2026-04-08
PrS Proposed sale
360
33.49
US$12,056 		360 33.49 US$12,056
2026-03-26 2026-03-25
PlS Planned sale
10,115 -3.4%
29.99
US$303,355 		10,115 -3.4% 29.99 US$303,355
2026-03-25 2026-03-25
PrS Proposed sale
10,115
28.25
US$285,749 		10,115 28.25 US$285,749
2026-01-02 2026-01-02
PrS Proposed sale
2,840
30.05
US$85,343 		2,840 30.05 US$85,343
2026-01-05 2025-12-31
S Sale
2,840 -0.9%
30.05
US$85,342 		2,840 -0.9% 30.05 US$85,342